Vincent K. Shier, Ph.D.
Vincent K. Shier, Ph.D. is a partner in the Intellectual Property Practice Group in Haynes Boone’s Washington, D.C. office.
Vince holds a doctorate degree in biological chemistry and has practiced IP law for more than two decades, preparing and prosecuting patent applications, counseling clients in strategic IP considerations, IP due diligence, and representing clients in post-grant proceedings at the U.S. Patent and Trademark Office (USPTO).
Another aspect of Vince’s work involves working with venture capital firms, private equity portfolio companies, startup biotechnology companies, and small-mid cap biotechnology and pharmaceutical companies. In this capacity, Vince advises venture capital firms on investable technologies and identification of complementary IP for in-licensing, as well as building developing strategies for portfolio companies to strategically align development of patent portfolios with company growth and objectives.
Drawing from his cross-disciplinary education, Vince’s practice focuses on representing clients in the biotechnology, life sciences, and pharmaceutical fields, as well as many chemical disciplines. These technologies include genetics, molecular biology, therapeutic methods, pharmaceuticals, DNA microarray technology, protein engineering, diagnostics, plants, FoodTech including alternate protein and cultivated meats, AgriTech, renewable energies, batteries, plastics, surface materials, minerals and mineral applications, along with an array of other chemical products and processes.
Vince has also served as an adjunct professor of law at the Antonin Scalia Law School at George Mason University from 2019 to 2021 teaching introductory patent law courses as well as course on patent and know-how licensing.
Litigation
- Plastic Omnium Advanced Innovation and Research v. Donghee America, Inc. et al., 1-16-cv-00187 (D.Del.)
- Medical Diagnostic Laboratories LLC v. Protagonist Therapeutics Inc., 3:17-cv-05572, (N.D.Cal.)
Inter Partes Review
- Donghee America, Inc. v. Plastic Omnium Advanced Innovation and Research, IPR2017-01602, USPTO Patent Trial and Appeal Board
- Donghee America, Inc. v. Plastic Omnium Advanced Innovation and Research, IPR2017-01605, USPTO Patent Trial and Appeal Board
- Donghee America, Inc. v. Plastic Omnium Advanced Innovation and Research, IPR2017-01633, USPTO Patent Trial and Appeal Board
- Donghee America, Inc. v. Plastic Omnium Advanced Innovation and Research, IPR2017-01647, USPTO Patent Trial and Appeal Board
- Donghee America, Inc. v. Plastic Omnium Advanced Innovation and Research, IPR2017-01654, USPTO Patent Trial and Appeal Board
- Donghee America, Inc. v. Plastic Omnium Advanced Innovation and Research, IPR2017-01890, USPTO Patent Trial and Appeal Board
- Donghee America, Inc. v. Plastic Omnium Advanced Innovation and Research, IPR2017-01945, USPTO Patent Trial and Appeal Board
- Librestream Technologies, Inc. v. Wireless Remote System LLC, IPR2014-00368, USPTO Patent Trial and Appeal Board
- Librestream Technologies, Inc. v. Wireless Remote System LLC, IPR2014-00369, USPTO Patent Trial and Appeal Board
- American Bar Association, Section of Intellectual Property Law
- Committees: Chemical and Life Sciences Patent; USPTO Ex-Parte Patent Practice and Policy; USPTO Post-Grant Patent Practice and Policy; IP Transactions & Licensing; Trade Secrets and Interference with Contracts
- Intellectual Property Owners Association (IPO)
- Patent Office Practice (U.S.) Committee; Patent Office Inter Partes Proceedings Committee
- American Intellectual Property Law Association (AIPLA)
- Chemical Practice Committee
- Biotechnology Committee
- PTAB Trial Committee
- Recognized by Intellectual Asset Management (IAM) Patent 1000: The World’s Leading Patent Practitioners, Globe White Page Ltd, as one of the top eighteen practitioners in the United States for post-grant proceedings and is a "Recommended" patent attorney in the Washington, D.C. Metro Area for patent prosecution, 2014-2023.
- "Fed. Circ. Args Don't Bode Well For Patent Term Adjustment," author, Law360, June 15, 2023.
- "Track Three Pilot Program," co-author, Haynes Boone client alert, May 31, 2023.
- "Is a (More than Pocket) Change in the Air at the USPTO?" co-author, Haynes Boone client alert, April 28, 2023.
- "Paper Patents are No More!" co-author, Haynes Boone client alert, March 1, 2023.
- "PTAB Ruling Shows Need To Split Terminal Disclaimer," co-author, Law360, May 26, 2022.
- Blog post: Is There Any Hope For Antibody Patents in the United States? (January 25, 2022)
- Webinar: Patent Term Adjustment - A Dollar Won is Twice as Sweet as a Dollar Earned (November 18-19, 2021)
- Webinar: Navigating the Conflict Between CAFC Case Law and USPTO Guidance on Patent Eligibility (August 11, 2021)
- Webinar: The Developing Enablement Law & Its Impact on Pharma (October 22, 2020)
- Webinar: The Developing Enablement Law & Its Impact on Pharma (October 15, 2020)
- Blog post: The USPTO Strikes Again: More First Action Final Rejections = More Money + Diminished Quality (September 17, 2020)
- Blog post: RCE/National Stage Kerfuffle: PTO Creates a Nightmare Scenario (August 6, 2020)
- Blog post: Final Rules on PTA Calculations in View of Supernus (June 24, 2020)
- Blog post: Update & Reminder: Patent Term Adjustment Related to IDS Safe Harbor (July 5, 2019)
- Blog post: USPTO's Patent Term Adjustment Policies Reigned in Yet Again (January 28, 2019)
- Blog post: USPTO Releases Interim Procedure for Requesting Recalculation of Patent Term Adjustment Related to the IDS Safe Harbor (November 9, 2018)
- Blog post: Is Real and Positive Change Coming for Patent Owners? (June 11, 2018)
- Mock IPR program (Japan, Belgium, and the Netherlands), 2016
- BioInno (Viterbo, Italy) September 17-19, 2014
- Using 35 USC 154(D) To Speed Interferences. Gholz CL and Shier VK, 19 Intellectual Property Today No. 5 at page 13 (May 2012)
- Is Dilatory Behavior In Provoking An Interference A "Failure To Engage In Reasonable Efforts To Conclude Prosecution Of The Application"? Gholz CL and Shier VK, 18 Intellectual Property Today No. 11 at page 8 (November 2011)
- Plant Biotechnology and Agriculture: Prospects for the 21st Century, edited by Arie Altman, Paul Michael Hasegawa, Oxford: Academic Press, 2011, pp. 525-540 (Chapter 33: Intellectual property rights of biotechnologically improved plants)
- GWU-India Project, 2006-2008
Education
J.D., George Washington University Law School, 2005
Ph.D., Biological Chemistry, Pennsylvania State University, 2001
B.A., Biological and Chemistry, University of Rochester, 1996
Admissions
District of Columbia
Virginia
U.S. Patent and Trademark Office
Court Admissions
U.S. Court of Appeals for the Federal Circuit
U.S. District Court for the Eastern District of Virginia
Haynes and Boone, LLP Lawyer Vincent Shier authored an article in Life Sciences IP Review on the basis for the decision in Cellect v Samsung and its practical impact, and posed a number of steps that patent owners and third parties should take. Read an excerpt below: In part 2 of articles assessing the impact of 'Cellect v Samsung', Vincent Shier of Haynes Boone now sets out what the future may [...]
Shier in Law360: Federal Circuit Arguments Don't Bode Well For Patent Term Adjustment
June 16, 2023